NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $349,974 | -91.3% | 7,909 | -90.5% | 0.00% | -87.5% |
Q2 2023 | $4,038,002 | -12.2% | 82,984 | +0.2% | 0.02% | +45.5% |
Q1 2023 | $4,597,667 | +37.5% | 82,811 | -0.5% | 0.01% | -47.6% |
Q4 2022 | $3,343,068 | +649.6% | 83,223 | +1636.0% | 0.02% | +200.0% |
Q4 2021 | $446,000 | -14.2% | 4,794 | +2.7% | 0.01% | -36.4% |
Q3 2021 | $520,000 | -62.5% | 4,669 | -61.8% | 0.01% | -63.3% |
Q2 2021 | $1,387,000 | +12.3% | 12,219 | +0.4% | 0.03% | +3.4% |
Q1 2021 | $1,235,000 | – | 12,166 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |